.png)
NextGen Biomed 2027
.svg)
InterContinental London - The O2, UK
.png?width=749&height=250&name=Vaccines%20Logo%20(drop%20shadow).png "Vaccines Logo (drop shadow)")
PART OF NEXTGEN BIOMED 2027
18 - 19 March 2027 | InterContinental London - The O2, London, UK
Delve into the latest in vaccines R&D: from advanced nucleotide-based platforms for infectious diseases, to antigen development, vaccine analytics & pre-clinical and clinical development for mRNA vaccines.
DANIEL LAROCQUE, Innovation Leader, Sanofi
Daniel Larocque, PhD, is Innovation Lead at Sanofi Vaccines and part of the External Scientific Affairs department. He is taking care of the scientific coordination with early biotech and universities. He has been human immunology and microbiology platform head. He is at Sanofi since 2015. Before, he has been a biotech entrepreneur and before he was Immunology head in Canada for GSK Vaccines (2007 to 2014). His special interests are related to vaccinology, new vaccines platforms, bringing immunotherapies into the traditional vaccines strategy.
See how AI is revolutionising vaccine R&D—from rapid antigen discovery and rational
design to smarter manufacturing, streamlined clinical trials, and regulatory-ready
development—delivering faster, more effective vaccines to patients worldwide.
leading pharma, biotech, regulatory & academic delegates
Unlock the Latest News and Insights
Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things NextGen Biomed, direct to your inbox.
Vaccines Agenda at a Glance
DAY ONE TRACKS
Track 10: Vaccine Platforms & Novel AI Driven Design Approaches
DAY TWO TRACKS
Track 9:
Part 1: Translational & Clinical Vaccine Development;
Part 2: Vaccine Analytics, Stability & Delivery for Infectious Diseases
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Partner with us
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients